Henry Schein, Inc. (HSIC)

NASDAQ · Health Care · Medical Distribution
By Alex · Tickerpine
$90.74
+1.56 (+1.75%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$10.11B
P/E (TTM)
26.0
Forward P/E
15.1
EPS (TTM)
$3.49
ROE
8.85%
Profit Margin
2.96%
Revenue Growth
6.70%
Dividend Yield
Beta
0.81
52W High
$92.18
52W Low
$61.95
Analyst Target
$97.56

HSIC stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$97.56
Implied upside
+7.5%

Wall Street analysts covering Henry Schein, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $97.56 — +7.5% versus the last price of $90.74. Targets reflect analyst opinion, not a guarantee.

What would an investment in HSIC be worth today?
Run HSIC through our free historical return calculator.
Calculate HSIC returns →

HSIC historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +30.4% +30.4% $1,304
3 years +18.6% +5.8% $1,186
5 years +20.0% +3.7% $1,200
10 years +41.3% +3.5% $1,413
20 years +364% +8.0% $4,640
Since 1995 +1,733% +9.9% $18,328

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in HSIC.

HSIC annual returns by year

2026 YTD +20.1%
2025 +9.2%
2024 -8.6%
2023 -5.2%
2022 +3.0%
2021 +16.0%
2020 +0.2%
2019 +8.3%
2018 +12.4%
2017 -7.9%

Congress trading in HSIC

9 members of Congress have disclosed trading HSIC — 4 purchases and 11 sales worth an estimated $358,502. Most recent disclosure: Apr 1, 2025.

See who in Congress traded HSIC →

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Company website ↗

HSIC Key Statistics

Previous Close$89.18P/E Ratio26.0
Market Cap$10.11BPEG Ratio2.01
Revenue (TTM)$13.60BROE8.85%
Gross Margin31.32%ROA4.39%
Debt / Equity80.7Employees25,000

HSIC in plain English

HSIC stock: frequently asked questions

What is Henry Schein, Inc.'s stock price today?

Henry Schein, Inc. (HSIC) last traded at $90.74 on the NASDAQ. Over the past 52 weeks the stock has traded between $61.95 and $92.18.

Is HSIC stock a buy or a sell?

Wall Street analysts' consensus rating on HSIC is "Buy", with an average 12-month price target of $97.56 — about +7.5% versus the current price of $90.74. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in HSIC 10 years ago be worth today?

A $1,000 investment in Henry Schein, Inc. made 10 years ago would be worth about $1,413 today (dividends reinvested) — a total return of 41%, or 3.5% per year.

Does HSIC pay a dividend?

No — Henry Schein, Inc. does not currently pay a meaningful dividend. Returns for shareholders come from changes in the share price.

What is HSIC's P/E ratio?

HSIC trades at a trailing price-to-earnings ratio of 26.0, and 15.1 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade HSIC stock?

Yes — 9 members of Congress have disclosed trades in HSIC under the STOCK Act, totaling 4 purchases and 11 sales worth an estimated $358,502.

What is Henry Schein, Inc.'s ticker symbol?

Henry Schein, Inc. trades under the ticker symbol HSIC on the NASDAQ.

Compare HSIC with peers

HSIC vs LLYEli Lilly and Company $1,220.28 HSIC vs JNJJohnson & Johnson $260.86 HSIC vs ABBVAbbVie Inc. $248.76 HSIC vs UNHUnitedHealth Group Incorporated $405.59 HSIC vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.